Pro Medicus, Ltd. PME

With Australia’s cash rate now at a 15-year high, money in the bank finally pays something again, but inflation and higher borrowing costs still eat into real wealth. That is why investors are paying closer attention to companies with solid returns on equity, resilient balance sheets and a history of holding up under pressure. This article highlights three such Australian stocks drawn from that quality focused group. The three examples in this piece are only a starting sample from that...

With Australian interest rates now at a 15-year high, cheap debt no longer does the heavy lifting for corporate performance. Investors are paying closer attention to who is actually steering each business. Founder led Australian companies, where the original builders still call key shots, can look appealing when capital is more expensive and decisions carry extra weight. This article highlights three such stocks from our founder focused screener. These three founder led Australian stocks are...

New rules on financial transparency in global supply chains are putting weak balance sheets under the microscope. Businesses that cannot clearly show lenders and customers they are financially sound may find contracts harder to win and funding tougher to access. That creates an opening for Australian companies with strong returns, healthy finances and disciplined track records. This article walks through three stocks that clear that higher bar. The three stocks covered below are just a sample...

Pro Medicus Ltd (PMCUF) reports a 30% constant currency growth, secures $407 million in new contracts, and unveils a new reporting tool poised to disrupt the market.

The S&P/ASX Small Ordinaries Index (ASX) closed yesterday at 3,570.80 points, up 0.60% or 21.30 points for the session. The index has gained 4.33%, or 148.30 points, over the past five trading days, reflecting a strong recent run for the small-cap end of the Australian market. Against...

Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will demonstrate the unmatched value of One Platform™, showcasing the complete set of capabilities and latest native AI optimized innovations for the industry-leading Visage 7 | CloudPACS powered by the Visage 7 Enterprise Imaging Platform ("Visage 7"), at the Society for Imaging Informatics in Medicine (SIIM) 2026 annual meeting, Booth 404, Pittsburgh, PA from Wednesday, June 10 – Friday,

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will highlight a series of released innovations for the industry-leading Visage 7 | CloudPACS, powered by the Visage 7 Enterprise Imaging Platform ("Visage 7"), at the Healthcare Information and Management Systems Society (HIMSS) 2026 annual meeting, Booth 3753, Las Vegas, NV from Tuesday, March 10 – Thursday, March 12, 2026.

The Australian stock market is experiencing a potential rebound, with shares expected to rise by over 1% following recent sell-offs, as investors anticipate the Reserve Bank of Australia's impending interest rate hike decision. In this dynamic environment, high-growth tech stocks can offer intriguing opportunities for investors seeking innovation and resilience amidst economic shifts and evolving global strategies.

Pro Medicus Limited ( ASX:PME ) shareholders might be concerned after seeing the share price drop 29% in the last...

Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will showcase a series of new innovations and events for the industry-leading Visage 7 | CloudPACS, powered by the Visage 7 Enterprise Imaging Platform ("Visage 7"), at the Radiological Society of North America (RSNA) 2025 annual meeting, Booth 4329, McCormick Place South Hall (Chicago, IL) from Sunday, November 30 – Wednesday, December 3, 2025.

As Australian shares brace for a challenging day with the ASX 200 futures indicating a significant drop, the market sentiment has been further unsettled by both domestic political shifts and international economic disruptions. In this climate, identifying high growth tech stocks requires careful consideration of their resilience to broader market volatility and their potential to capitalize on evolving technological trends amidst uncertain conditions.

Amidst a backdrop where Australian shares are charting their own course with a modest gain, diverging from the cautious sentiment seen on Wall Street, the tech sector continues to capture attention as it benefits from positive earnings and favorable trade developments. In this environment, identifying promising stocks involves looking at companies that can leverage these conditions for growth, such as Wisetech Global and two other noteworthy Australian tech firms poised for potential expansion.

As of October 2025, the Australian market has shown resilience with the S&P/ASX 200 index climbing past the 9,000-point mark despite mixed economic signals such as weak jobs data and stronger-than-expected inflation. In this dynamic environment, identifying high-growth tech stocks requires careful consideration of factors like market sentiment shifts and sector-specific developments that could influence their performance.